GYRE vs HUM · rev $53.5M vs P/E 39, rev $129.66B
Gyre Therapeutics Inc. (GYRE) versus Humana Inc (HUM) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
GYRE currently screens at market cap $589.9M. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Not investment advice. Open the GYRE and HUM stock pages for the full models.
Not investment advice.